FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Pramipexole Dihydrochloride (Mirapex) Tablets
Status: Discontinuation
»Therapeutic Categories: Neurology

Expand all

Boehringer Ingelheim Pharmaceuticals, Inc. (New 11/06/2018)

Company Contact Information:
800-542-6257

Presentation Posting Date Related Information
0.25 mg tablets (NDCs 0597-0184-61 and 0597-0184-90) 11/06/2018 This product discontinuation is a business related decision.
0.125 mg tablets (NDC 0597-0183-90) 11/06/2018 This product discontinuation is a business related decision.
0.5 mg tablets (NDCs 0597-0185-61 and 0597-0185-90) 11/06/2018 This product discontinuation is a business related decision.
0.75 mg tablets (NDC 0597-0101-90) 11/06/2018 This product discontinuation is a business related decision.
1 mg tablets (NDCs 0597-0190-61 and 0597-0190-90) 11/06/2018 This product discontinuation is a business related decision.
1.5 mg tablets (NDCs 0597-0191-61 and 0597-0191-90) 11/06/2018 This product discontinuation is a business related decision.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English